Department of Dermatology, Second Xiangya Hospital of Central South University, Changsha, China.
Clinical Medical Research Center of Major Skin Diseases and Skin Health of Hunan Province, Changsha, China.
Dermatol Ther. 2022 Dec;35(12):e15942. doi: 10.1111/dth.15942. Epub 2022 Nov 3.
We here report a case of a middle-aged man with an unusual case of bullous lichen sclerosus complicated with generalized morphea. He showed initial recurrent flaccid bullae, followed by ivory-white sclerotic plaques and extensive skin sclerosis, with additional walking disorder caused by knee-joint contracture, and ulcers on the lower extremities and back. The patient had no visceral involvement. After oral hydroxychloroquine and oral corticosteroids failed, the patient was given tofacitinib, which resolved his ulcers after 4 weeks and ameliorated his knee-joint contracture and skin sclerosis within 4 months. Owing to the occurrence of diffuse large B-cell lymphoma, he stopped using tofacitinib, and the ulcer and walking disorder reappeared. This is rare case of bullous lichen sclerosus-generalized morphea overlap syndrome. The patient recovered well after treatment with tofacitinib. His symptoms recurred after discontinuation of tofacitinib.
我们在此报告一例中年男性,患有不寻常的大疱性硬化性苔藓合并全身性硬皮病。他最初表现为复发性松弛性大疱,随后出现象牙白色硬化性斑块和广泛的皮肤硬化,伴有膝关节挛缩引起的行走障碍以及下肢和背部溃疡。患者无内脏受累。羟氯喹和口服皮质类固醇治疗失败后,给予托法替尼治疗,4 周后溃疡消退,4 个月内膝关节挛缩和皮肤硬化得到改善。由于弥漫性大 B 细胞淋巴瘤的发生,他停止使用托法替尼,溃疡和行走障碍再次出现。这是一例罕见的大疱性硬化性苔藓-全身性硬皮病重叠综合征。该患者经托法替尼治疗后恢复良好。停用托法替尼后症状复发。